[A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002927:Cimetidine / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000517:prevention & control; D005663:Furans / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D011899:Ranitidine; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy
D000897:Anti-Ulcer Agents; D005663:Furans; D006635:Histamine H2 Antagonists; D002927:Cimetidine; D011899:Ranitidine
Ein neuer H2-Rezeptor-Antagonist in der Behandlung gastrointestinaler Erkrankungen.